Acthar Gel (repository corticotropin injection) 400 USP units/5mL (80 USP units/mL), 5mL multiple-dose vial, Rx only, Mfd. for: Mallinckrodt ARD LLC, Bridgewater, NJ 08807, NDC 63004-8710-1
Published February 28, 2024 · Recall initiated: February 6, 2024
Summary
FDA records drug Class II recall D-0340-2024, published February 28, 2024 and initiated February 6, 2024. Recalling firm: Mallinckrodt Hospital Products Inc.; Status: Ongoing; Reported quantity: 8 vials involved in recall (16,479 vials distributed); Lot: Lot #: 1564-103, Exp 9/30/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.
What to do
Voluntary: Firm initiated · Letter
Get an email if ACTHAR has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ACTHAR
- Manufacturer
- Mallinckrodt Hospital Products Inc.
- Distributor
- USA nationwide
- UPC
- 0363004871213
- Lot
- Lot #: 1564-103, Exp 9/30/2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAActhar Gel (repository corticotropin injection), 5 mL multiple-dose vial, Rx Only, Mfd. for: Mallinckrodt ARDSeptember 2, 2026
- FDAFosfomycin Tromethamine Granules for Oral Solution, (equivalent to 3 grams of fosfomycin), single-dose sachet,February 28, 2024
- FDATerlivaz (terlipressin for injection), 0.85mg/vial, Single-Dose Vial, Rx only, Distributed by: MallinckrodtFebruary 28, 2024
- FDAPure Care Foaming Mint Hand Sanitizer 62%, Distributed by: Air Scent International, 290 Alpha Drive, RIDCFebruary 28, 2024
- FDAAdrenalin (epinephrine) Injection 1mg/mL, 1mL single dose vial, Rx only, Packaged By: Henry Schein, Inc., 80February 28, 2024
- FDAVoriconazole for Oral Suspension, 40mg/mL, Orange-Flavored, 49g/75mL when reconstituted. Mixing Directions:February 28, 2024
Questions about this recall
Was Acthar Gel (repository corticotropin injection) 400 USP units/5mL (80 USP units/mL), 5mL multiple-dose vial, Rx only, Mfd. for: Mallinckrodt ARD LLC, Bridgewater, NJ 08807, NDC 63004-8710-1 recalled?
Yes. FDA published recall D-0340-2024 on February 28, 2024. Reported hazard: cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ACTHAR. UPC: 0363004871213.